[144] Hims & Hers Health, Inc. SEC Filing

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) filing a Form 144 notifies the proposed sale of 65,110 Class A shares through Fidelity Brokerage Services on 09/17/2025 with an aggregate market value of $3,292,903.57. The shares were acquired by restricted stock vesting on 09/15/2025 and paid as compensation. The filing also lists multiple Class A sales by Andrew Dudum and the Dudum Family Trust during the past three months, including sizable single-month transactions on 07/21/2025, 08/18/2025 and 09/16/2025. The filer certifies they are not aware of any undisclosed material adverse information and provides broker details and seller addresses as required by Rule 144.

Positive

• Transparent disclosure of proposed sale details including broker, sale date, share count, and aggregate market value
• Acquisition source clearly stated as restricted stock vesting and payment as compensation
• Complete sale history for the past three months provided for the relevant sellers

Negative

• Multiple large insider sales listed in the past three months, including transactions of 125,335 and 128,127 shares
• Proposed sale represents a non-trivial market value ($3,292,903.57) that could increase available float when executed

Insights

Securities Analyst

TL;DR: Officer-related restricted shares vested and are being sold; several large recent dispositions are disclosed, which could affect float near-term.

The filing shows a 65,110-share proposed sale tied to restricted stock vesting and compensation, executed through Fidelity on 09/17/2025. The schedule of recent transactions reveals multiple substantial disposals by Andrew Dudum and an affiliated trust across June–September 2025, including transactions of 125,335 and 128,127 shares. For investors, these disclosures clarify insider liquidity and timing but do not include company operational metrics or forward guidance.

Corporate Governance Expert

TL;DR: The Form 144 complies with Rule 144 disclosure requirements and documents insider sales tied to compensation vesting.

The notice specifies the relationship to the issuer through compensatory restricted stock vesting and contains the signature representation regarding material nonpublic information. It lists broker and seller contact details and shows aggregation of prior sales by the same parties. The filing provides the standard legal attestation and transaction chronology necessary for transparent insider sale reporting.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	65110	3292903.57	217641958	09/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/15/2025	Restricted Stock Vesting	Issuer			65110	09/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Andrew Dudum 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/17/2025	65110	3855543.59
Andrew Dudum 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/16/2025	2792	141216.51
Dudum Family Community Property Trust Dtd 03/04/21 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/16/2025	47534	2388816.19
Andrew Dudum 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/21/2025	125335	6208636.66
Andrew Dudum 2269 Chestnut Street #523 San Francisco CA 94123	Class A	08/18/2025	128127	5773247.84
Dudum Family Community Property Trust Dtd 03/04/21 2269 Chestnut Street #523 San Francisco CA 94123	Class A	08/18/2025	47534	2141494.49
Andrew Dudum 2269 Chestnut Street #523 San Francisco CA 94123	Class A	09/16/2025	128127	6852297.12
Dudum Family Community Property Trust Dtd 03/04/21 2269 Chestnut Street #523 San Francisco CA 94123	Class A	09/16/2025	47534	2532326.31

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What Class A shares does the HIMS Form 144 propose to sell?

The notice proposes to sell 65,110 Class A shares through Fidelity Brokerage Services on 09/17/2025.

How were the shares being sold acquired according to the filing?

The shares were acquired via restricted stock vesting on 09/15/2025 and the payment is listed as compensation.

What is the aggregate market value of the proposed sale?

The filing reports an aggregate market value of $3,292,903.57 for the 65,110 shares.

Does the Form 144 disclose recent insider sales for HIMS?

Yes; it lists multiple Class A sales by Andrew Dudum and the Dudum Family Trust during Jun–Sep 2025, with individual transactions including 125,335 and 128,127 shares.

Through which broker will the sale be executed?

The sale is to be executed through Fidelity Brokerage Services LLC at the address shown in the filing.